Home/ Supplements/ Vitamin C/ Corvita 150

Corvita 150

product on market Tablet or Pill Trigen Laboratories Safety: 94/100
94/100

This product looks safe

  • Folate: 2083mg is 2083.0× the Tolerable Upper Intake Level (1.0mg)
  • 67% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This profile contains B vitamins, folate, and iron, which are supported by strong evidence for maintaining red blood cell production and neurological function. Vitamin C further aids in iron absorption and immune support. Research consistently validates these nutrients for addressing specific deficiencies.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Folate: 2083mg is 2083.0× the Tolerable Upper Intake Level (1.0mg)

Label

Product Label

Label for Corvita 150
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
150
Servings
Multi-Vitamin and Mineral (MVM)
Product Type
67%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin C
120 mg (133% DV)
10 mg (588% DV)
7.7× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
2083 mcg DFE (521% DV)
Exceeds UL by 2083.0× (UL: 1.0 mg) 226 studies (A:10, B:105)
15 mcg (625% DV)
6.2× RDA — above typical dose 139 studies (A:1, B:44)
Iron
150 mg (833% DV)
25 mg (227% DV)
2.3× RDA — within safe limits 263 studies (A:6, B:134)

Other Ingredients

Microcrystalline Cellulose pregelatinized Starch Polyvinyl Alcohol Polyethylene Glycol FD&C Red #40 Lake Talc Titanium Dioxide Croscarmellose Sodium Magnesium Stearate Stearic Acid
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions for use Take one tablet by mouth daily or as directed by a physician.

Warnings & Precautions

Contraindications: Corvita 150 should not be used by patients with a known hypersensitivity to any of the listed ingredients. All iron compounds are contraindicated in patients with hemochromatosis, hemosiderosis, or hemolytic anemias.

Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

Precautions General: Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with Corvita 150. Since the anemia may be a result of a systemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.

Folic Acid: Folic acid alone is an improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

Pediatric Use: Safety and effectiveness in pediatric populations have not been established.

Geriatric Use: Safety and effectiveness in elderly populations have not been established.

Drug Interactions There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).

Adverse Reactions Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.

Overdosage The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools, melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanosis, lassitude, seizures, shock and coma.

Call your doctor about side effects. To report side effects, call Trigen Laboratories at 1-888-9-TRIGEN (1-877-987-4436) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Formulation Notes

Corvita 150 is a prescription multivitamin/multimineral supplement used to improve the nutritional status of patients with iron deficiency

Iron Supplementation

Gluten-, Lactose- and Sugar-free

Additional Information

Corvita 150 is a red, oval bisected tablet imprinted with “VP031”.

How supplied Corvita 150 tablets are supplied in unit dose packs of 100 (10 blister cards of 10 tablets each).

Storage Store at 20 degrees -25 degrees C (68 degrees -77 degrees F), excursions permitted to 15 degrees-30 degrees C (59 degrees-86 degrees F) [See USP Controlled Room Temperature]. Protect from light and moisture and avoid excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.

For use on the order of a healthcare practitioner

Customer Service: 1-888-987-4436

Product Code: 13811-066-10

Metadata

Product Details

UPC / SKU3 13811 066 10 4
DSLD Entry Date2021-12-18
Product TypeMulti-Vitamin and Mineral (MVM)
FormTablet or Pill
DSLD ID264418
Data Updated2026-04-11
Research

Research Evidence

371
Research Sources
54
Avg Quality
148
Meta Analysis
82
Systematic Review
71
Rct
62
Clinical Trial
2
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Other
1
Openfda Safety
A Vitamin C supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for the primary prevention of cardiovascular disease
Systematic Review The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin C for preventing and treating the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin C for preventing and treating pneumonia
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Vitamin E supplementation in pregnancy
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Vitamin C supplementation for prevention and treatment of pneumonia
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Nutritional interventions for preventing and treating pressure ulcers
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Does Vitamin C Supplementation Provide a Protective Effect in Periodontal Health? A Systematic Review and Meta-Analysis
Meta Analysis International journal of molecular sciences 2024 PubMed DOI
A Circulating vitamin C concentration and risk of cancers: a Mendelian randomization study
Meta Analysis BMC medicine 2021 PubMed DOI
View all evidence for Vitamin C →
Compare

Similar Products

View all Vitamin C products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.